Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
In8Bio Inc
(NQ:
INAB
)
0.5170
+0.0099 (+1.95%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about In8Bio Inc
IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 09, 2024
From
IN8bio, Inc
Via
GlobeNewswire
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
April 30, 2024
From
IN8bio, Inc
Via
GlobeNewswire
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
April 24, 2024
From
IN8bio, Inc
Via
GlobeNewswire
IN8bio Inc. (NASDAQ: INAB) Near the Top of Equities by Percentage Gain on 4/24
April 24, 2023
Via
Investor Brand Network
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
April 16, 2024
From
IN8bio, Inc
Via
GlobeNewswire
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
April 09, 2024
From
IN8bio, Inc
Via
GlobeNewswire
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
March 14, 2024
From
IN8bio, Inc
Via
GlobeNewswire
IN8bio to Present at Upcoming Investor Conferences
February 26, 2024
From
IN8bio, Inc.
Via
Business Wire
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June
May 31, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:JAZZ),(NASDAQ:GERN),(NASDAQ:INAB),(NASDAQ:VCYT) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.